The effect of green tea consumption on prostate cancer risk and progression: a systematic review

Sabrina Anne Jacob, Tahir Mehmood Khan, Learn-Han Lee

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

This systematic review aimed to assess the clinical benefits of green tea consumption on the progression and prevention of prostate cancer (PCa). A systematic search was performed across the following databases: PubMed, Excerpta Medica dataBASE, Database of Abstracts of Reviews of Effects, Current Nursing and Allied Health Literature, Allied and Complementary Medicine Database, Cochrane Database of Systematic Reviews, and Cochrane Central Register of Controlled Trials. We included studies from database inception to September 2015. Studies must report on the effect of green tea consumption on PCa. The quality of observational studies was assessed using the Newcastle-Ottawa Scale (NOS), while randomized controlled trials (RCTs) were assessed for quality using the Jadad scale. A total of 15 articles were included, with 11 reporting on the effect of green tea consumption on PCa prevention, and four reporting on the effect of green tea on treatment. Mean NOS for observational studies was 7.4 (SD±1.3), with a range from 6 to 9, while all three RCTs scored 5 on the Jadad scale. Findings demonstrate that green tea appears to be an effective chemopreventive agent, particularly in those with high-grade prostate intraepithelial neoplasia. However, evidence of efficacy in the treatment of PCa is currently lacking. Given the limitations in current studies, more well-designed RCTs should be undertaken to determine if green tea indeed has a role in the prevention and treatment of PCa.

Original languageEnglish
Pages (from-to)353-364
Number of pages12
JournalNutrition and Cancer
Volume69
Issue number3
Early online date17 Feb 2017
DOIs
Publication statusPublished - 30 Apr 2017

Keywords

  • prostate cancer
  • PCa
  • green tea
  • systematic review

Cite this